Office of the Secretary; Notice of Meeting, 37595-37596 [2017-16915]
Download as PDF
Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices
Individuals or organizations that wish
to make a 5-minute oral presentation on
an agenda topic should submit a written
copy of the oral presentation to the DFO
at the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice. The
number of oral presentations may be
limited by the time available.
Individuals not wishing to make an oral
presentation may submit written
comments to the DFO at the address
listed in the ADDRESSES section of this
notice by the date listed in the DATES
section of this notice.
III. Security and Building
The meeting is open to the public, but
attendance is limited to the space
available. Persons wishing to attend this
meeting must register by contacting the
DFO at the address listed in the
ADDRESSES section of this notice or by
telephone at the number listed in the
FOR FURTHER INFORMATION CONTACT
asabaliauskas on DSKBBXCHB2PROD with NOTICES
section of this notice by the date
specified in the DATES section of this
notice.
Since this meeting will be held in a
Federal Government Building, the
Hubert H. Humphrey Building, Federal
security measures are applicable. In
planning your arrival time, we
recommend allowing additional time to
clear security. To gain access to the
building, participants will be required
to show a government-issued photo
identification (for example, driver’s
license or passport), and must be listed
on an approved security list before
persons are permitted entrance. Persons
not registered in advance will not be
permitted into the Hubert H. Humphrey
Building and will not be permitted to
attend the Panel meeting.
All persons entering the building
must pass through a metal detector. In
addition, all items brought to the Hubert
H. Humphrey Building, whether
personal or for the purpose of
presentation, are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set-up, safety, or
timely arrival of any personal
belongings or items used for the purpose
of presentation.
Authority: 42 U.S.C. 217a, sec. 222 of the
Public Health Service Act, as amended; 42
U.S.C. 1314(f), sec. 1114(f) of the Social
Security Act; and Public Law 92–463, as
amended (5 U.S.C. App. 2).
Dated: August 2, 2017.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2017–16979 Filed 8–10–17; 8:45 am]
BILLING CODE 4120–01–P
VerDate Sep<11>2014
17:18 Aug 10, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Macula
Degenerative Diseases
Date: August 23, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Nataliya Gordiyenko,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5202,
MSC 7846, Bethesda, MD 20892,
301.435.1265, gordiyenkon@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 7, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–16914 Filed 8–10–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Muscular Dystrophy
Coordinating Committee (MDCC).
The meeting will be open to the
public and accessible by live webcast.
Attendance is limited to space available.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
37595
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Muscular Dystrophy
Coordinating Committee.
Type of meeting: Open Meeting.
Date: October 4, 2017.
Time: 8:30 a.m. to 4:30 p.m. *Eastern
Time*—Approximate end time.
Agenda: Agenda: The purpose of this
meeting is to bring together committee
members, representing government agencies,
patient advocacy groups, other voluntary
health organizations, and patients and their
families to update one another on progress
relevant to the Action Plan for the Muscular
Dystrophies and to coordinate activities and
discuss gaps and opportunities leading to
better understanding of the muscular
dystrophies, advances in treatments, and
improvements in patients’ and their families’
lives. Prior to the meeting, an agenda will be
posted to the MDCC meeting registration Web
site: https://meetings.ninds.nih.gov/
meetings/Oct42017/.
Registration: To register, please go to:
https://meetings.ninds.nih.gov/meetings/
Oct42017/.
Webcast Live: For those not able to attend
in person, this meeting will be webcast at:
https://videocast.nih.gov/.
Place: Neuroscience Center, Conference
Room C/D, 6001 Executive Boulevard,
Rockville, Maryland 20852.
Contact Person: Glen H. Nuckolls, Ph.D.,
Executive Secretary, Muscular Dystrophy
Coordinating Committee, National Institute
of Neurological Disorders and Stroke, NIH,
6001 Executive Boulevard, NSC 2203,
Bethesda, MD 20892, (301) 496–5745,
glen.nuckolls@ninds.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
All visitors must go through a security
check at the building entrance to receive a
visitor’s badge. A government issued photo
ID is required. Further information can be
found at the registration Web site: https://
meetings.ninds.nih.gov/meetings/Oct42017/.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
E:\FR\FM\11AUN1.SGM
11AUN1
37596
Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: August 4, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–16915 Filed 8–10–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2017–0002; Internal
Agency Docket No. FEMA–B–1738]
Proposed Flood Hazard
Determinations
Comments are requested on
proposed flood hazard determinations,
which may include additions or
modifications of any Base Flood
Elevation (BFE), base flood depth,
Special Flood Hazard Area (SFHA)
boundary or zone designation, or
regulatory floodway on the Flood
Insurance Rate Maps (FIRMs), and
where applicable, in the supporting
Flood Insurance Study (FIS) reports for
the communities listed in the table
below. The purpose of this notice is to
seek general information and comment
regarding the preliminary FIRM, and
where applicable, the FIS report that the
Federal Emergency Management Agency
(FEMA) has provided to the affected
communities. The FIRM and FIS report
are the basis of the floodplain
management measures that the
community is required either to adopt
or to show evidence of having in effect
in order to qualify or remain qualified
for participation in the National Flood
Insurance Program (NFIP). In addition,
the FIRM and FIS report, once effective,
will be used by insurance agents and
others to calculate appropriate flood
insurance premium rates for new
buildings and the contents of those
buildings.
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
17:18 Aug 10, 2017
The Preliminary FIRM, and
where applicable, the FIS report for
each community are available for
inspection at both the online location
and the respective Community Map
Repository address listed in the tables
below. Additionally, the current
effective FIRM and FIS report for each
community are accessible online
through the FEMA Map Service Center
at www.msc.fema.gov for comparison.
You may submit comments, identified
by Docket No. FEMA–B–1738, to Rick
Sacbibit, Chief, Engineering Services
Branch, Federal Insurance and
Mitigation Administration, FEMA, 400
C Street SW., Washington, DC 20472,
(202) 646–7659, or (email)
patrick.sacbibit@fema.dhs.gov.
ADDRESSES:
Rick
Sacbibit, Chief, Engineering Services
Branch, Federal Insurance and
Mitigation Administration, FEMA, 400
C Street SW., Washington, DC 20472,
(202) 646–7659, or (email)
patrick.sacbibit@fema.dhs.gov; or visit
the FEMA Map Information eXchange
(FMIX) online at
www.floodmaps.fema.gov/fhm/fmx_
main.html.
FOR FURTHER INFORMATION CONTACT:
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
AGENCY:
VerDate Sep<11>2014
Comments are to be submitted
on or before November 9, 2017.
DATES:
Jkt 241001
FEMA
proposes to make flood hazard
determinations for each community
listed below, in accordance with section
110 of the Flood Disaster Protection Act
of 1973, 42 U.S.C. 4104, and 44 CFR
67.4(a).
These proposed flood hazard
determinations, together with the
floodplain management criteria required
by 44 CFR 60.3, are the minimum that
are required. They should not be
construed to mean that the community
must change any existing ordinances
that are more stringent in their
floodplain management requirements.
The community may at any time enact
stricter requirements of its own or
pursuant to policies established by other
Federal, State, or regional entities.
These flood hazard determinations are
used to meet the floodplain
management requirements of the NFIP
and also are used to calculate the
appropriate flood insurance premium
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
rates for new buildings built after the
FIRM and FIS report become effective.
The communities affected by the
flood hazard determinations are
provided in the tables below. Any
request for reconsideration of the
revised flood hazard information shown
on the Preliminary FIRM and FIS report
that satisfies the data requirements
outlined in 44 CFR 67.6(b) is considered
an appeal. Comments unrelated to the
flood hazard determinations also will be
considered before the FIRM and FIS
report become effective.
Use of a Scientific Resolution Panel
(SRP) is available to communities in
support of the appeal resolution
process. SRPs are independent panels of
experts in hydrology, hydraulics, and
other pertinent sciences established to
review conflicting scientific and
technical data and provide
recommendations for resolution. Use of
the SRP only may be exercised after
FEMA and local communities have been
engaged in a collaborative consultation
process for at least 60 days without a
mutually acceptable resolution of an
appeal. Additional information
regarding the SRP process can be found
online at https://floodsrp.org/pdfs/srp_
fact_sheet.pdf.
The watersheds and/or communities
affected are listed in the tables below.
The Preliminary FIRM, and where
applicable, FIS report for each
community are available for inspection
at both the online location and the
respective Community Map Repository
address listed in the tables. For
communities with multiple ongoing
Preliminary studies, the studies can be
identified by the unique project number
and Preliminary FIRM date listed in the
tables. Additionally, the current
effective FIRM and FIS report for each
community are accessible online
through the FEMA Map Service Center
at www.msc.fema.gov for comparison.
(Catalog of Federal Domestic Assistance No.
97.022, ‘‘Flood Insurance.’’)
Dated: July 31, 2017.
Roy E. Wright,
Deputy Associate Administrator for Insurance
and Mitigation, Department of Homeland
Security, Federal Emergency Management
Agency.
I. Non-watershed-based studies:
E:\FR\FM\11AUN1.SGM
11AUN1
Agencies
[Federal Register Volume 82, Number 154 (Friday, August 11, 2017)]
[Notices]
[Pages 37595-37596]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16915]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Muscular Dystrophy
Coordinating Committee (MDCC).
The meeting will be open to the public and accessible by live
webcast. Attendance is limited to space available. Individuals who plan
to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
Name of Committee: Muscular Dystrophy Coordinating Committee.
Type of meeting: Open Meeting.
Date: October 4, 2017.
Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*--Approximate end
time.
Agenda: Agenda: The purpose of this meeting is to bring together
committee members, representing government agencies, patient
advocacy groups, other voluntary health organizations, and patients
and their families to update one another on progress relevant to the
Action Plan for the Muscular Dystrophies and to coordinate
activities and discuss gaps and opportunities leading to better
understanding of the muscular dystrophies, advances in treatments,
and improvements in patients' and their families' lives. Prior to
the meeting, an agenda will be posted to the MDCC meeting
registration Web site: https://meetings.ninds.nih.gov/meetings/Oct42017/.
Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/Oct42017/.
Webcast Live: For those not able to attend in person, this
meeting will be webcast at: https://videocast.nih.gov/.
Place: Neuroscience Center, Conference Room C/D, 6001 Executive
Boulevard, Rockville, Maryland 20852.
Contact Person: Glen H. Nuckolls, Ph.D., Executive Secretary,
Muscular Dystrophy Coordinating Committee, National Institute of
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard,
NSC 2203, Bethesda, MD 20892, (301) 496-5745,
glen.nuckolls@ninds.nih.gov.
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
All visitors must go through a security check at the building
entrance to receive a visitor's badge. A government issued photo ID
is required. Further information can be found at the registration
Web site: https://meetings.ninds.nih.gov/meetings/Oct42017/.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
[[Page 37596]]
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: August 4, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-16915 Filed 8-10-17; 8:45 am]
BILLING CODE 4140-01-P